QNCX: Quince Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Quince Therapeutics Inc (QNCX).
$82.28M Market Cap.
QNCX Market Cap. (MRY)
QNCX Shares Outstanding (MRY)
QNCX Assets (MRY)
Total Assets
$114.48M
Total Liabilities
$84.33M
Total Investments
$34.57M
QNCX Income (MRY)
Revenue
$0
Net Income
-$56.83M
Operating Expense
$53.30M
QNCX Cash Flow (MRY)
CF Operations
-$31.90M
CF Investing
$21.91M
CF Financing
-$4.78M
QNCX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $114,478,000 (-31.82%) | $167,900,000 (61.58%) | $103,910,000 (-22.01%) | $133,228,000 (-29.68%) |
Assets Current | $44,036,000 (-43.14%) | $77,440,000 (-17.40%) | $93,748,000 (-16.05%) | $111,673,000 (-19.00%) |
Assets Non-Current | $70,442,000 (-22.13%) | $90,460,000 (790.18%) | $10,162,000 (-52.86%) | $21,555,000 (-58.23%) |
Goodwill & Intangible Assets | $60,045,000 (-26.14%) | $81,297,000 (1277.92%) | $5,900,000 (0%) | $0 (0%) |
Shareholders Equity | $30,146,000 (-64.57%) | $85,084,000 (-15.42%) | $100,593,000 (-15.17%) | $118,586,000 (-31.16%) |
Property Plant & Equipment Net | $813,000 (31.34%) | $619,000 (-9.50%) | $684,000 (-52.10%) | $1,428,000 (29.70%) |
Cash & Equivalents | $6,212,000 (-70.07%) | $20,752,000 (-53.45%) | $44,579,000 (-36.06%) | $69,724,000 (4.31%) |
Accumulated Other Comprehensive Income | -$35,000 (-101.15%) | $3,047,000 (1154.33%) | -$289,000 (-265.82%) | -$79,000 (-125.24%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $34,572,000 (-36.34%) | $54,307,000 (10.42%) | $49,180,000 (-13.74%) | $57,011,000 (-51.46%) |
Investments Current | $34,572,000 (-36.34%) | $54,307,000 (19.09%) | $45,602,000 (22.99%) | $37,078,000 (-44.64%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $3,578,000 (-82.05%) | $19,933,000 (-60.50%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,903,000 (42.79%) | $2,033,000 (256.67%) | $570,000 (-88.39%) | $4,911,000 (38.14%) |
Accumulated Retained Earnings (Deficit) | -$376,472,000 (-17.78%) | -$319,644,000 (-10.89%) | -$288,259,000 (-21.83%) | -$236,599,000 (-61.33%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $4,963,000 (-6.43%) | $5,304,000 (2038.71%) | $248,000 (0%) | $0 (0%) |
Total Debt | $14,715,000 (7.02%) | $13,750,000 (0%) | $0 (0%) | $420,000 (101.92%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $14,715,000 (7.02%) | $13,750,000 (0%) | $0 (0%) | $420,000 (101.92%) |
Total Liabilities | $84,332,000 (1.83%) | $82,816,000 (2396.71%) | $3,317,000 (-77.35%) | $14,642,000 (-14.89%) |
Liabilities Current | $7,278,000 (-23.97%) | $9,572,000 (211.89%) | $3,069,000 (-78.42%) | $14,222,000 (-16.32%) |
Liabilities Non-Current | $77,054,000 (5.20%) | $73,244,000 (29433.87%) | $248,000 (-40.95%) | $420,000 (101.92%) |
QNCX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $17,580,000 (-0.65%) | $17,695,000 (-31.97%) | $26,012,000 (-11.89%) | $29,523,000 (67.88%) |
Research & Development Expense | $18,590,000 (96.78%) | $9,447,000 (-62.48%) | $25,178,000 (-58.59%) | $60,795,000 (-0.84%) |
Operating Expenses | $53,300,000 (61.31%) | $33,042,000 (-36.48%) | $52,015,000 (-42.41%) | $90,318,000 (14.48%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $87,000 (144.16%) | -$197,000 (30.63%) | -$284,000 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$56,828,000 (-81.07%) | -$31,385,000 (39.25%) | -$51,660,000 (42.56%) | -$89,945,000 (-17.04%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$56,828,000 (-81.07%) | -$31,385,000 (39.25%) | -$51,660,000 (42.56%) | -$89,945,000 (-17.04%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$56,828,000 (-81.07%) | -$31,385,000 (39.25%) | -$51,660,000 (42.56%) | -$89,945,000 (-17.04%) |
Weighted Average Shares | $43,262,269 (16.18%) | $37,237,149 (11.17%) | $33,496,534 (12.71%) | $29,718,506 (1.86%) |
Weighted Average Shares Diluted | $43,262,269 (16.18%) | $37,237,149 (11.17%) | $33,496,534 (12.71%) | $29,718,506 (1.86%) |
Earning Before Interest & Taxes (EBIT) | -$56,741,000 (-79.66%) | -$31,582,000 (39.20%) | -$51,944,000 (42.25%) | -$89,945,000 (-17.04%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$53,300,000 (-61.31%) | -$33,042,000 (36.48%) | -$52,015,000 (42.41%) | -$90,318,000 (-14.48%) |
QNCX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $21,908,000 (480.48%) | -$5,758,000 (-131.99%) | $18,002,000 (-69.46%) | $58,952,000 (212.44%) |
Net Cash Flow from Financing | -$4,775,000 (-3439.16%) | $143,000 (-79.77%) | $707,000 (-89.62%) | $6,808,000 (-94.27%) |
Net Cash Flow from Operations | -$31,904,000 (-74.42%) | -$18,292,000 (58.46%) | -$44,038,000 (30.02%) | -$62,932,000 (-23.84%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$14,540,000 (38.98%) | -$23,827,000 (5.24%) | -$25,145,000 (-972.18%) | $2,883,000 (-81.55%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$2,116,000 (-119.98%) | $10,593,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $22,165,000 (720.52%) | -$3,572,000 (-147.81%) | $7,472,000 (-87.36%) | $59,132,000 (212.89%) |
Capital Expenditure | -$257,000 (-267.14%) | -$70,000 (-11.11%) | -$63,000 (65.00%) | -$180,000 (-246.15%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$6,000 (87.76%) | -$49,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $225,000 (51.01%) | $149,000 (-80.29%) | $756,000 (-88.90%) | $6,808,000 (-94.27%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $231,000 (188.75%) | $80,000 (-56.52%) | $184,000 (234.55%) | $55,000 (0%) |
Share Based Compensation | $4,746,000 (-9.08%) | $5,220,000 (-68.59%) | $16,618,000 (-44.33%) | $29,853,000 (106.31%) |
Depreciation Amortization & Accretion | $186,000 (-42.24%) | $322,000 (57.84%) | $204,000 (-40.70%) | $344,000 (3.61%) |
QNCX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -115.80% (-218.13%) | -36.40% (25.41%) | -48.80% (25.38%) | -65.40% (-66.84%) |
Return on Average Assets (ROAA) | -42.50% (-47.57%) | -28.80% (37.66%) | -46.20% (20.89%) | -58.40% (-60.44%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -88.60% (-67.80%) | -52.80% (45.40%) | -96.70% (29.47%) | -137.10% (-124.02%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.43 (-14.16%) | -1.25 (-201.93%) | -0.41 (90.06%) | -4.17 (60.57%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 2.73 (415.88%) | 0.53 (131.00%) | 0.23 (-92.80%) | 3.18 (-33.15%) |
Debt to Equity Ratio (D/E) | 2.8 (187.46%) | 0.97 (2848.48%) | 0.03 (-73.17%) | 0.12 (23.00%) |
Earnings Per Share (EPS) | -1.31 (-55.95%) | -0.84 (45.45%) | -1.54 (49.17%) | -3.03 (-15.21%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.74 (-50.71%) | -0.49 (62.57%) | -1.32 (37.99%) | -2.12 (-21.79%) |
Book Value Per Share (BVPS) | 0.7 (-69.50%) | 2.29 (-23.91%) | 3 (-24.74%) | 3.99 (-32.42%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.26 (-45.92%) | 2.33 (-20.51%) | 2.93 (-34.73%) | 4.48 (-30.97%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (-100.00%) | -1 (0%) | 0 (0%) | -4 (60.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.68 (-124.47%) | -0.75 (-542.60%) | 0.17 (104.80%) | -3.52 (64.34%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 6.05 (-25.20%) | 8.09 (-73.52%) | 30.55 (289.03%) | 7.85 (-3.19%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$32,161,000 (-75.15%) | -$18,362,000 (58.36%) | -$44,101,000 (30.12%) | -$63,112,000 (-24.07%) |
Enterprise Value (EV) | $94,957,072 (306.14%) | $23,380,394 (367.92%) | -$8,726,543 (-102.77%) | $315,458,413 (-58.24%) |
Earnings Before Tax (EBT) | -$56,741,000 (-79.66%) | -$31,582,000 (39.20%) | -$51,944,000 (42.25%) | -$89,945,000 (-17.04%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$56,555,000 (-80.92%) | -$31,260,000 (39.58%) | -$51,740,000 (42.26%) | -$89,601,000 (-17.10%) |
Invested Capital | $55,658,000 (-20.52%) | $70,029,000 (39.05%) | $50,362,000 (1.33%) | $49,702,000 (-53.04%) |
Working Capital | $36,758,000 (-45.84%) | $67,868,000 (-25.16%) | $90,679,000 (-6.95%) | $97,451,000 (-19.37%) |
Tangible Asset Value | $54,433,000 (-37.15%) | $86,603,000 (-11.64%) | $98,010,000 (-26.43%) | $133,228,000 (-29.68%) |
Market Capitalization | $82,283,072 (82.80%) | $45,012,394 (95.46%) | $23,029,457 (-93.89%) | $377,055,413 (-53.99%) |
Average Equity | $49,055,750 (-43.17%) | $86,326,000 (-18.37%) | $105,759,000 (-23.06%) | $137,450,500 (-29.85%) |
Average Assets | $133,779,500 (22.89%) | $108,860,000 (-2.73%) | $111,920,000 (-27.39%) | $154,139,000 (-27.00%) |
Invested Capital Average | $64,037,750 (7.06%) | $59,813,250 (11.37%) | $53,706,750 (-18.15%) | $65,613,750 (-47.72%) |
Shares | 44,001,643 (2.64%) | 42,868,947 (18.65%) | 36,130,306 (20.93%) | 29,877,608 (1.29%) |